HK Stock Market Move | LEADS BIOLABS-B(09887) has increased by over 3%, and 5 research results in the field of blood tumors will be announced at the 2025 ASH Annual Meeting.

LEADS BIOLABS-B (09887) rose by more than 3%, reaching a 3.49% increase at the time of writing, trading at 57.9 Hong Kong dollars with a trading volume of 20.2056 million Hong Kong dollars. On the news front, on November 4, LEADS BIOLABS-B announced that 5 research abstracts were selected to be presented at the 67th annual meeting of the American Society of Hematology. The company happily provided further details on its innovative drugs LBL-034 and LBL-076, with multiple research abstracts on these drugs being included in the 67th ASH annual meeting. One clinical study on LBL-034 was selected to be the first oral presentation on the opening day of the conference, showcasing the latest efficacy and safety data of LBL-034 for relapsed/refractory multiple myeloma patients.